Literature DB >> 7765112

Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines.

O W Merten1, J V Kierulff, N Castignolles, P Perrin.   

Abstract

The presence of serum in cell culture raises safety problems for the production of biologicals, thus a new serum-free medium (MDSS2) was developed. The evaluation of this medium for the growth of different cell lines (BHK-21 C13, BSR and Vero) has shown that cells grew in this medium similarly to standard serum-containing medium, independently of the culture system used: in static (as monolayer) as well as in agitated systems (in suspension in spinner and perfusion reactors). BHK-21 and BSR cells grew as aggregate cultures and could proliferate in both static and agitated culture systems. Vero cells stayed attached to a substrate and proliferated equally in static and in agitated microcarrier-culture systems. The cell densities obtained with BHK-21 cells depended only on the culture system used. They ranged from 2-3 x 10(6) to 6-12 x 10(6) cells per ml for static batch and perfusion reactor cultures respectively. The cell concentration was 3 to 6 times higher than in classical cultures performed in serum-containing medium. The cell densities obtained with Vero cells were indistinguishable from those obtained in serum-containing medium, whatever the cell culture system used. These cell lines have been used for the production of rabies virus. With respect to BHK-21 and BSR, similar production rates of rabies glycoprotein have been found as in the standard roller bottle process. The production of rabies virus and of viral glycoprotein by Vero cells cultivated in serum-free medium was augmented 1.5-fold and 2.5-fold, respectively, when compared to serum-containing medium. A recombinant BHK-21 cell line, producing human IL-2, can also proliferate in MDSS2, after addition of insulin. The specific IL-2 production rate was augmented 3-4-fold in comparison to serum-containing medium. For the cells tested, the MDSS2 serum-free medium is a good growth and production medium. Its use for cultivating other cell lines and/or for the production of other biologicals is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7765112     DOI: 10.1007/BF00772195

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  26 in total

Review 1.  Serum-free medium for fermentor cultures of hybridomas.

Authors:  O W Merten; J Litwin
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

2.  Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence.

Authors:  I MACPHERSON; M STOKER
Journal:  Virology       Date:  1962-02       Impact factor: 3.616

3.  Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process.

Authors:  T W Pay; A Boge; F J Menard; P J Radlett
Journal:  Dev Biol Stand       Date:  1985

4.  Enhancement of interleukin-2 activity by liposomes.

Authors:  M L Joffret; S Morgeaux; C Laclerc; D Oth; C Zanetti; P Sureau; P Perrin
Journal:  Vaccine       Date:  1990-08       Impact factor: 3.641

5.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

6.  Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine. Promising results.

Authors:  B Montagnon; J C Vincent-Falquet; B Fanget
Journal:  Dev Biol Stand       Date:  1983

7.  The cultivation of animal cells and production of viruses in serum-free system.

Authors:  L Keay
Journal:  Methods Cell Biol       Date:  1978       Impact factor: 1.441

8.  Serum-free growth medium for the cultivation of a wide spectrum of mammalian cells in stirred bioreactors.

Authors:  V Jäger; J Lehmann; P Friedl
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

9.  Human erythropoietin gene: high level expression in stably transfected mammalian cells and chromosome localization.

Authors:  J S Powell; K L Berkner; R V Lebo; J W Adamson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

10.  Production of recombinant human interleukin-2 with BHK cells in a hollow fibre and a stirred tank reactor with protein-free medium.

Authors:  T Ryll; M Lucki-Lange; V Jäger; R Wagner
Journal:  J Biotechnol       Date:  1990-06       Impact factor: 3.307

View more
  12 in total

1.  Adaptation of mammalian cells to growth in serum-free media.

Authors:  M S Sinacore; D Drapeau; S R Adamson
Journal:  Mol Biotechnol       Date:  2000-07       Impact factor: 2.695

2.  Evaluation of the serum-free medium MDSS2 for the production of poliovirus on vero cells in bioreactors.

Authors:  O W Merten; R Wu; E Couvé; R Crainic
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

3.  The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses.

Authors:  O W Merten; H Kallel; J C Manuguerra; M Tardy-Panit; R Crainic; F Delpeyroux; S Van der Werf; P Perrin
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

4.  Guidelines for cultivation and preservation of the serum-free cell line McCoy-Plovdiv.

Authors:  Marian M Draganov; Marianna A Murdjeva; Victoria S Sarafian
Journal:  Cytotechnology       Date:  2003-09       Impact factor: 2.058

5.  Semliki Forest Virus replicon particles production in serum-free medium BHK-21 cell cultures and their use to express different proteins.

Authors:  Sandra Fernanda Suárez-Patiño; Thaissa Consoni Bernardino; Eutimio Gustavo Fernández Núñez; Renato Mancini Astray; Carlos Augusto Pereira; Hugo R Soares; Ana S Coroadinha; Soraia Attie Calil Jorge
Journal:  Cytotechnology       Date:  2019-08-17       Impact factor: 2.058

6.  Cell culture as a substrate for the production of influenza vaccines: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

7.  Kinetics and metabolic specificities of Vero cells in bioreactor cultures with serum-free medium.

Authors:  Sébastien Quesney; Annie Marc; Catherine Gerdil; Cyrille Gimenez; Jacqueline Marvel; Yves Richard; Bernard Meignier
Journal:  Cytotechnology       Date:  2003-05       Impact factor: 2.058

8.  Characterization of Vero cell growth and death in bioreactor with serum-containing and serum-free media.

Authors:  S Quesney; J Marvel; A Marc; C Gerdil; B Meignier
Journal:  Cytotechnology       Date:  2001-03       Impact factor: 2.058

9.  Detachment factors for enhanced carrier to carrier transfer of CHO cell lines on macroporous microcarriers.

Authors:  K Landauer; M Dürrschmid; H Klug; S Wiederkum; G Blüml; O Doblhoff-Dier
Journal:  Cytotechnology       Date:  2002-05       Impact factor: 2.058

10.  Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.

Authors:  Allen Chen; Swan Li Poh; Christian Dietzsch; Elisabeth Roethl; Mylene L Yan; Say Kong Ng
Journal:  BMC Biotechnol       Date:  2011-08-11       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.